These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 30081853)

  • 1. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.
    Srisuttee R; Arayataweegool A; Mahattanasakul P; Tangjaturonrasme N; Kerekhanjanarong V; Keelawat S; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2020 Mar; 20(1):218. PubMed ID: 32171289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal penalized regression (Elastic-net) model with differentially methylated promoters for oral cancer prediction.
    Das S; Karuri S; Chakraborty J; Basu B; Chandra A; Aravindan S; Chakraborty A; Paul D; Ray JG; Lechner M; Beck S; Teschendorff AE; Chatterjee R
    Eur J Med Res; 2024 Sep; 29(1):458. PubMed ID: 39261895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.
    Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
    Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
    BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
    Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
    Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
    Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
    Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
    Guerrero-Preston R; Soudry E; Acero J; Orera M; Moreno-López L; Macía-Colón G; Jaffe A; Berdasco M; Ili-Gangas C; Brebi-Mieville P; Fu Y; Engstrom C; Irizarry RA; Esteller M; Westra W; Koch W; Califano J; Sidransky D
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1061-72. PubMed ID: 21558411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer.
    Anić P; Golubić Talić J; Božinović K; Dediol E; Mravak-Stipetić M; Grce M; Milutin Gašperov N
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation profiles and biomarkers of oral squamous cell carcinoma.
    Li YF; Hsiao YH; Lai YH; Chen YC; Chen YJ; Chou JL; Chan MW; Lin YH; Tsou YA; Tsai MH; Tai CK
    Epigenetics; 2015; 10(3):229-36. PubMed ID: 25612142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma.
    Dai Y; Lv Q; Qi T; Qu J; Ni H; Liao Y; Liu P; Qu Q
    Cancer Med; 2020 May; 9(9):3174-3187. PubMed ID: 32155325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.